CLINICAL_TRIALS
trial_result
· 2010-05-26
Clinical Trial Update: Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 study of sorafenib in patients with metastatic renal cell carcinoma has completed; sponsored by the Egyptian Foundation For Cancer Research.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Egyptian Foundation For Cancer Research | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED